Kolexia
Even Caroline
Oncologie médicale
Gustave-Roussy
Villejuif, France
259 Activités
202 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Récidive tumorale locale Tumeurs des glandes salivaires Métastase tumorale Sarcomes Tumeurs oto-rhino-laryngologiques

Industries

BMS
14 collaboration(s)
Dernière en 2021
MSD
14 collaboration(s)
Dernière en 2023
Merck-Serono
11 collaboration(s)
Dernière en 2022
Seagen
2 collaboration(s)
Dernière en 2023

Dernières activités

innovaTV 207: Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
Essai Clinique (Seagen)   15 mars 2024
iintune-1: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Essai Clinique (Takeda Pharmaceutical)   07 mars 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
The Lancet. Healthy longevity   05 mars 2024
French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment.
Bulletin du cancer   27 février 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
Salivary gland carcinoma: Towards a more personalised approach.
Cancer treatment reviews   12 février 2024
Carcinomas of the external auditory canal: Management and results: A multicenter REFCOR propensity score matching study.
European journal of cancer (Oxford, England : 1990)   10 février 2024
National standard for the treatment of squamous cell carcinoma of upper aerodigestive tract.
Bulletin du cancer   08 février 2024
ELAN-UNFIT: Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
Essai Clinique (Merck-Serono)   07 février 2024
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158): A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
Essai Clinique (Merck & Co.)   02 février 2024